# Difference-in-Differences Analysis Summary
==================================================

## Key Findings

### Diabetes × Age Group
- **DiD Estimate**: 0.0141
- **Sample Size**: 6,664
- **R²**: 0.0432
- **Interpretation**: DiD estimate: 0.0141

### Diabetes × Education
- **DiD Estimate**: 0.0004
- **Sample Size**: 6,695
- **R²**: 0.0651
- **Interpretation**: DiD estimate: 0.0004

### Diabetes × Region
- **DiD Estimate**: -0.0016
- **Sample Size**: 7,278
- **R²**: 0.0031
- **Interpretation**: DiD estimate: -0.0016

### Diabetes × Insurance
- **DiD Estimate**: 0.0078
- **Sample Size**: 7,278
- **R²**: 0.0175
- **Interpretation**: DiD estimate: 0.0078

### Treatment × Diabetes
- **DiD Estimate**: 0.0000
- **Sample Size**: 7,278
- **R²**: 0.0031
- **Interpretation**: DiD estimate: 0.0000

## Policy Implications

1. **Causal Inference**: DiD analysis provides stronger causal evidence than cross-sectional analysis
2. **Treatment Effects**: Different treatment definitions reveal varying effects of diabetes on privacy
3. **Heterogeneity**: Effects vary across demographic groups and contexts
4. **Policy Design**: Results inform targeted privacy policies for diabetic patients
